ATX.AX
Amplia Therapeutics Ltd
Price:  
0.08 
AUD
Volume:  
339,346.00
Australia | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ATX.AX Stock Forecast & Price Target

ATX.AX Stock Price Forecast

The average stock forecast for Amplia Therapeutics Ltd (ATX.AX) in the next 12 months is 0.43 AUD. This price target corresponds to an upside of 449.23%. The range of stock forecasts for ATX.AX is 0.42 - 0.44 AUD. Based on the ratings of 5 analysts, the consensus recommendation for ATX.AX is BUY.
Target Low Average Median High
Price (AUD) 0.42 0.43 0.43 0.44
Upside 443.85% 449.23% 449.23% 465.38%

Recommendation Trends

The latest consensus rating for ATX.AX is "BUY". This is the average recommendation of 5 analysts: 0 strong sell, 0 sell, 1 hold, 3 buy, 1 strong buy. In the previous period, 5 analysts also majorly recommmended "BUY" for ATX.AX.

ATX.AX Financial Stock Forecast

Revenue This Year
-M
-100.00%
from 3.77M
Revenue Next Year
10.10M
from -M
EPS This Year
-0.02
9.63%
from -0.02
EPS Next Year
-0.02
-%
from -0.02